Patents Assigned to CTxT Pty Limited
  • Patent number: 11613525
    Abstract: A compound of formula (I), wherein R1 is selected from (i) H, (ii) C3-6cycloalkyl, (iii) C3-7heterocyclyl optionally substituted with a group selected from: methyl and ester, and (iv) linear or branched C1-4alkyl optionally substituted with a group selected from: alkoxy, amino, amido, acylamido, acyloxy, alkyl carboxyl ester, alkyl carbamoyl, alkyl carbamoyl ester, phenyl, phosphonate ester, C3-7heterocyclyl optionally substituted with a group selected from methyl and oxo, and a naturally occurring amino acid, optionally N-substituted with a group selected from methyl, acetyl and boc; A1 is CRA or N; A2 is CRB or N; A3 is CRC or N; A4 is CRD or N; where no more than two of A1, A2, A3, and A4 may be N; one or two of RA, RB, RC, and RD, (if present) are selected from H, F, Cl, Br, Me, CF3, cyclopropyl, cyano, OMe, OEt, CH2OH, CH2OMe and CH2NMe2; the remainder of RA, RB, RC, and RD, (if present) are H; Y is O, NH or CH2; RY is selected from: (RYA) and (RYB).
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: March 28, 2023
    Assignee: CTXT PTY LIMITED
    Inventors: Benjamin Joseph Morrow, Michelle Ang Camerino, Scott Raymond Walker, Graeme Irvine Stevenson, Paul Anthony Stupple
  • Publication number: 20200039945
    Abstract: A compound of formula (I), or a pharmaceutical salt thereof:
    Type: Application
    Filed: June 20, 2019
    Publication date: February 6, 2020
    Applicant: CTxT Pty Limited
    Inventors: Helen Rachel Lagiakos, Benjamin Joseph Morrow, Richard Charles Foitzik, Catherine Fae Hemley, Michelle Ang Camerino, Paul Anthony Stupple, Ylva Elisabet Bergman Bozikis, Scott Raymond Walker